Study supports triple combination therapy for HIV
New evidence in this week’s BMJ supports the use of up to three antiviral drugs (triple therapy) to treat people with HIV.
Researchers in Birmingham reviewed 54 trials involving over 20,000 patients with HIV infection who had not already received antiviral therapy.
Combinations of up to three drugs were consistently and significantly more effective, but there was inadequate evidence on the effectiveness of quadruple or higher combinations. There was also marked variation, mainly accounted for by the drugs tested and issues of quality, say the authors.
Further work is needed to clarify which triple combination is the most effective and to investigate the effectiveness of quadruple or higher combinations, conclude the authors.
Media Contact
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Perovskite solar cells soar to new heights
Metal halide perovskites have been under intense investigation over the last decade, due to the remarkable rise in their performance in optoelectronic devices such as solar cells or light-emitting diodes….
Blue hydrogen can help protect the climate
An international group of researchers led by the Paul Scherrer Institute and the Heriot-Watt University has carried out in-depth analyses of the climate impact of blue hydrogen. This is produced…
Genes associated with hearing loss visualised in new study
Researchers from Uppsala University have been able to document and visualise hearing loss-associated genes in the human inner ear, in a unique collaboration study between otosurgeons and geneticists. The findings…
